SGP

Healthcare Biotechnology

SpyGlass Pharma, Inc.

$25.20

-0.73 -2.82% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 6, 2026, live at 1:20 PM ET	25.20

Key Stats

Market Cap

842.89M

Avg Volume

112,860

EPS

-$2.51

52W High

$32.44

52W Low

$17.06

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-9.38

P/B Ratio

3.63

EV/EBITDA

-10.20

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Liquidity & Leverage

Current Ratio

25.06

Quick Ratio

24.89

Debt / Equity

0.01

Total Cash

234.19M

Total Debt

1.63M

About

SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was formerly known as SpyGlass Ophthalmics, Inc. and changed its name to SpyGlass Pharma, Inc. in April 2021. The company was headquartered in 2019 and is based in Irvine, California.